Skip to content
Open access

Dissecting the angiogenic mechanism of pachychoroid polypoidal choroidal vasculopathy

Sep 2026 · iMeta · Vol 5 · 0 citations · 78 references
Medicine

TL;DR

A pathogenic cascade wherein CCH induces abnormal hemodynamics (disrupted fluid shear stress) and drives angiogenesis via the EDN1/EDNRA axis is defined, offering mechanistic insight and identifying a potential therapeutic target for pachychoroid PCV.

Abstract

Abstract Polypoidal choroidal vasculopathy (PCV) is a distinct variant of neovascular age‐related macular degeneration (AMD) and a major cause of vision loss in older adults, yet its pathogenesis remains poorly understood. Pachychoroid PCV is a subtype characterized by poor treatment response, minimal typical AMD features, and dilated choroidal vessels. Using a multicenter PCV cohort, we conducted plasma multi‐omics analyses and identified enrichment of fluid shear stress and atherosclerosis (FSS‐AS) signaling pathways in this subtype. The pachychoroid phenotype, together with FSS‐AS enrichment, implicated altered choroidal hemodynamics in its pathogenesis. By inducing choroidal circulatory hypertension (CCH) in mice, we recapitulated, for the first time, the hallmark ocular lesions of pachychoroid PCV. Single‐cell sequencing identified the cellular origin of these angiogenic lesions and implicated endothelin‐1 (EDN1) as a key effector. Alleviating choroidal hypertension, reducing EDN1 expression, or pharmacologically blocking the endothelin receptor A (EDNRA, the receptor for EDN1), prevented lesion formation. In vitro, disturbed fluid shear stress upregulated EDN1 in choroidal endothelial cells and promoted pathological remodeling and angiogenesis through EDNRA. Collectively, our findings define a pathogenic cascade wherein CCH induces abnormal hemodynamics (disrupted fluid shear stress) and drives angiogenesis via the EDN1/EDNRA axis, offering mechanistic insight and identifying a potential therapeutic target for pachychoroid PCV.

Read PDF

Similar papers

Review Oct 2026

The Clinical Significance of Polypoidal Lesion Regression in Polypoidal Choroidal Vasculopathy - A Review.

Achieving complete polypoidal lesion regression is a critical clinical endpoint for ensuring long-term disease stability and reducing the risk of catastrophic recurrence and should nonetheless be regarded as one of several important endpoints - alongside visual acuity, exudative control, safety, and treatment accessibi...

Jun-Wei Chen, De-Kuang Hwang, Yi-Ting Hsieh et al. · 0 citations
Open access Oct 2026

Loss of Farnesoid X Receptor Signaling Promotes Choroidal Neovascularization in Mice

Choroidal neovascularization (CNV) is a defining feature of neovascular age-related macular degeneration (nAMD). Although anti-vascular endothelial growth factor (VEGF) therapies suppress neovascular activity, incomplete responses, recurrent leakage, and subretinal fibrosis remain important clinical challenges. The far...

Chanel Harris, M. Nisar, Ankit Seth et al. · 0 citations
Case report Open access Sep 2026

Choroidal Circulation in Indolent, Nonprogressive, Multifocal Choroidal Lesions Evaluated by Multimodal Imaging Including Laser Speckle Flowgraphy

Background: Indolent, nonprogressive, multifocal choroidal lesions (INMCLs) are low-grade B-cell lymphoid infiltration with a good visual prognosis, yet their impact on choroidal circulation remains poorly understood. Clinical Significance: We report two cases of INMCLs evaluated via multimodal imaging, focusing on cir...

Yui Yamashita, Mizuho Mitamura, Michiyuki Saito et al. · 0 citations
Open access Jan 2026

Bilateral Choroidal Neovascular Membranes in a Patient With a C1QTNF5 Mutation Managed With Long‐Term Anti‐VEGF Therapy and PRN Protocol: A Case Report

Choroidal neovascular membranes (CNVM) are abnormal vascular complexes that can cause serious visual morbidity if untreated. They can be induced by the C1QTNF5 mutation, which disrupts retinal pigment epithelium (RPE) adhesion and leads to progressive sub‐RPE deposit accumulation. Due to its overlapping clinical presen...

Zi-Shuai Chou, C. Saade · 0 citations
Review Oct 2026

[Are pachychoroid diseases really a continuum?]

Whether pachychoroid macular diseases represent a true disease continuum remains unresolved and a cautious, nonlinear spectrum model with possible but not obligatory progression pathways is therefore preferable to the assumption of one single disease evolving through fixed stages.

L. Pauleikhoff, C. von der Burchard, C. Lange · 0 citations
Review Sep 2026

Targeting the choroidal neovascularization microenvironment: new perspectives in nanotherapeutic strategies.

An in-depth exploration of advanced nano-therapeutic strategies designed to multi-target angiogenic pathways, dynamically manipulate reactive oxygen species, disrupt hypoxia-driven feedback loops, reprogram the immunoinflammatory network, and restore defective cellular autophagy are provided.

Xiao-Yan Lu, Bo Li, Bao-Yuan Sun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.